Chronic Lymphocytic Leukemia (CLL)
Chronic lymphocytic leukemia (CLL) is one of the most commonly diagnosed forms of leukemia in the United States.1
- CLL is generally incurable, and usually follows an indolent course2,3
- CLL accounted for an estimated 20,110 diagnoses and 4660 deaths in 20174
- CLL is most frequently diagnosed among people aged 65-74, with a median age of diagnosis of 70 years4
- Many patients with CLL have at least one coexisting medical condition5
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5-29.
- Brenner H, Gondos A, Pulte D. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood. 2008;111:4916-4921.
- Pileri SA, Ascani S, Sabattini E, et al. The pathologist’s view point. Part I – indolent lymphomas. Haematologica. 2000;85:1295-1307.
- SEER Stat Fact Sheets: Chronic Lymphocytic Leukemia (CLL). Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/statfacts/html/clyl.html. Updated 2017. Accessed August 23, 2017.
- Thurmes P, Call T, Slager S, et al. Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2008;49:49-56.